What is the recommended dosing schedule for lurasidone (Latuda) in adults with schizophrenia and bipolar I depression, including dose adjustments for hepatic impairment and CYP3A4 inhibitors or inducers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Latuda Dosing Schedule

Latuda (lurasidone) should be started at 40 mg once daily for adults with schizophrenia and 20 mg once daily for adults with bipolar I depression, taken with at least 350 calories of food, with no initial titration required. 1

Schizophrenia Dosing

Adults

  • Starting dose: 40 mg once daily
  • Effective range: 40-160 mg/day
  • Maximum dose: 160 mg/day
  • No initial titration required 1

Adolescents (13-17 years)

  • Starting dose: 40 mg once daily
  • Effective range: 40-80 mg/day
  • Maximum dose: 80 mg/day
  • No initial titration required 1

Bipolar I Depression Dosing

Adults (Monotherapy or Adjunctive with Lithium/Valproate)

  • Starting dose: 20 mg once daily
  • Effective range: 20-120 mg/day
  • Maximum dose: 120 mg/day
  • No initial titration required
  • Important note: The 80-120 mg/day range did not provide additional efficacy compared to 20-60 mg/day in monotherapy studies 1

Pediatric Patients (10-17 years, Monotherapy)

  • Starting dose: 20 mg once daily
  • Dose adjustment: May increase after one week based on clinical response
  • Effective range: 20-80 mg/day
  • Maximum dose: 80 mg/day
  • Clinical note: 67% of patients in trials received 20-40 mg/day 1

Recent meta-analysis data suggests 40-60 mg/day is optimal for bipolar depression, balancing efficacy with side effect burden 2. Asian expert consensus recommends a starting dose of 20 mg/day with titration up to 120 mg/day as needed 3.

Critical Administration Requirement

Latuda MUST be taken with food (at least 350 calories) to ensure adequate absorption. Food increases:

  • AUC approximately 2-fold
  • Cmax approximately 3-fold 1, 4, 5

Without food, bioavailability is substantially reduced, potentially leading to treatment failure.

Dose Adjustments for Hepatic Impairment

Moderate Hepatic Impairment (Child-Pugh Score 7-9)

  • Starting dose: 20 mg/day
  • Maximum dose: 80 mg/day 1

Severe Hepatic Impairment (Child-Pugh Score 10-15)

  • Starting dose: 20 mg/day
  • Maximum dose: 40 mg/day 1

Dose Adjustments for Renal Impairment

Moderate Renal Impairment (CrCl 30 to <50 mL/min)

  • Starting dose: 20 mg/day
  • Maximum dose: 80 mg/day 1

Severe Renal Impairment (CrCl <30 mL/min)

  • Starting dose: 20 mg/day
  • Maximum dose: 80 mg/day 1

Drug Interactions: CYP3A4 Considerations

Lurasidone is primarily metabolized by CYP3A4, requiring careful attention to drug interactions 4, 5.

Strong CYP3A4 Inhibitors (e.g., ketoconazole, clarithromycin, ritonavir)

  • CONTRAINDICATED - Do not use Latuda with strong CYP3A4 inhibitors 1, 4

Moderate CYP3A4 Inhibitors (e.g., diltiazem, erythromycin, fluconazole)

  • Starting dose: 20 mg/day
  • Maximum dose: 80 mg/day 1

Strong CYP3A4 Inducers (e.g., rifampin, phenytoin, carbamazepine, St. John's Wort)

  • CONTRAINDICATED - Do not use Latuda with strong CYP3A4 inducers 1, 4

Moderate CYP3A4 Inducers

  • May require dose increase; monitor clinical response 1

Genetic Considerations

CYP3A4 rs2242480 genotype influences lurasidone clearance:

  • CC carriers: 25% lower clearance compared to TT carriers
  • TC carriers: 14% lower clearance compared to TT carriers
  • Consider lower doses in CC carriers, particularly when targeting AUC of 167 mg·h·L⁻¹ (optimal efficacy threshold) 6

Special Populations

Elderly Patients

Asian expert consensus recommends a lower dose range of 20-80 mg/day with careful monitoring 3

Pregnancy

Exercise caution, particularly in the first trimester 3

Common Pitfalls to Avoid

  1. Forgetting food requirement: Always emphasize the 350-calorie minimum with each dose
  2. Exceeding 80 mg/day in schizophrenia without benefit: Doses above 80 mg/day may increase side effects (somnolence, akathisia) without additional efficacy 4, 7
  3. Missing CYP3A4 interactions: Always screen for strong inhibitors/inducers before prescribing
  4. Over-titrating in bipolar depression: The 20-60 mg/day range is often sufficient; higher doses (80-120 mg/day) showed no additional benefit in monotherapy 1
  5. Inadequate trial duration: Allow at least 4-6 weeks at therapeutic dose before declaring treatment failure 8

Monitoring

  • Efficacy assessment: Evaluate response at 4-6 weeks 8
  • Side effects: Monitor for akathisia, extrapyramidal symptoms, somnolence, and nausea 9, 7
  • Metabolic profile: Lurasidone has minimal impact on weight, glucose, and lipids 4, 5, 7
  • Long-term use: Periodically re-evaluate necessity beyond 6 weeks, as long-term efficacy data is limited 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.